Xiromed LLC

General

Total Cases3

Active Cases1

Patents--

CourtsD. Delaware D. New Jersey

TypeOperating Company

Elite Ratings

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
05/09/23	Fresenius Kabi USA LLC v. Xiromed Pharma Espana SL 3:22-CV-06220 ( D. NJ )	STIPULATION AND ORDER OF DISMISSAL without prejudice. Signed by Judge Michael A. Shipp on 5/8/2023. (jdg) (Entered: 05/09/2023)
05/08/23	Fresenius Kabi USA LLC v. Xiromed Pharma Espana SL 3:22-CV-06220 ( D. NJ )	STIPULATION of Dismissal by FRESENIUS KABI USA, LLC. (QUINN, JUSTIN) (Entered: 05/08/2023)
04/06/23	Fresenius Kabi USA LLC v. Xiromed Pharma Espana SL 3:22-CV-06220 ( D. NJ )	STIPULATION AND ORDER granting 30 day extension to stay to reach a settlement agreement. Signed by Magistrate Judge Rukhsanah L. Singh on 4/5/2023. (mg) (Entered: 04/06/2023)
04/05/23	Fresenius Kabi USA LLC v. Xiromed Pharma Espana SL 3:22-CV-06220 ( D. NJ )	STIPULATION AND CONSENT ORDER REGARDING STAY by XIROMED PHARMA ESPANA, S.L., XIROMED, LLC. (RODRIGUEZ, LISA) (Entered: 04/05/2023)
02/23/23	Arius Two Inc v. Xiromed LLC 1:22-CV-01196 ( D. DE )	REDACTED VERSION of (17 in 1:22-cv-01196-CFC, 508 in 1:19-cv-00444-CFC-CJB) Letter by Arius Two, Inc., BioDelivery Sciences International, Inc.. (Attachments: # 1 Exs. 1-9)(Tigan, Jeremy) (Entered: 02/23/2023)
02/23/23	Arius Two Inc v. Xiromed LLC 1:22-CV-01196 ( D. DE )	SO ORDERED, re (23 in 1:22-cv-01196-CFC, 515 in 1:19-cv-00444-CFC-CJB) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 24, 2023, filed by Insud Pharma S.L.U., IntelGenx Corp., IntelGenX Technologies Corp., Xiromed, LLC, Chemo Research, S.L., Insud Pharma S.L., IntelGenx Technologies Corp. Signed by Judge Colm F. Connolly on 2/23/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(kmd) (Entered: 02/23/2023) SO ORDERED, re (23 in 1:22-cv-01196-CFC, 515 in 1:19-cv-00444-CFC-CJB) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 24, 2023, filed by Insud Pharma S.L.U., IntelGenx Corp., IntelGenX Technologies Corp., Xiromed, LLC, Chemo Research, S.L., Insud Pharma S.L., IntelGenx Technologies Corp. Signed by Judge Colm F. Connolly on 2/23/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(kmd) (Entered: 02/23/2023)
02/22/23	Arius Two Inc v. Xiromed LLC 1:22-CV-01196 ( D. DE )	STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 24, 2023 - filed by Chemo Research, S.L., Insud Pharma S.L.U., IntelGenx Corp., IntelGenx Technologies Corp., Xiromed, LLC, Insud Pharma S.L.. (Wilson, Samantha) (Entered: 02/22/2023)
02/17/23	Arius Two Inc v. Xiromed LLC 1:22-CV-01196 ( D. DE )	STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 22, 2023 - filed by Arius Two, Inc., BioDelivery Sciences International, Inc.. (Tigan, Jeremy) (Entered: 02/17/2023)
02/17/23	Arius Two Inc v. Xiromed LLC 1:22-CV-01196 ( D. DE )	SO ORDERED, re (22 in 1:22-cv-01196-CFC, 514 in 1:19-cv-00444-CFC-CJB) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 22, 2023 filed by BioDelivery Sciences International, Inc., Arius Two, Inc. Signed by Judge Colm F. Connolly on 2/17/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(nmf) (Entered: 02/17/2023) SO ORDERED, re (22 in 1:22-cv-01196-CFC, 514 in 1:19-cv-00444-CFC-CJB) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 22, 2023 filed by BioDelivery Sciences International, Inc., Arius Two, Inc. Signed by Judge Colm F. Connolly on 2/17/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(nmf) (Entered: 02/17/2023)
02/15/23	Arius Two Inc v. Xiromed LLC 1:22-CV-01196 ( D. DE )	SO ORDERED, re (513 in 1:19-cv-00444-CFC-CJB, 21 in 1:22-cv-01196-CFC) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC to February 17, 2023 filed by Insud Pharma S.L.U., IntelGenx Corp., IntelGenX Technologies Corp., Xiromed, LLC, Chemo Research, S.L., Insud Pharma S.L., IntelGenx Technologies Corp. Signed by Judge Colm F. Connolly on 2/15/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(nmf) (Entered: 02/15/2023) SO ORDERED, re (513 in 1:19-cv-00444-CFC-CJB, 21 in 1:22-cv-01196-CFC) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC to February 17, 2023 filed by Insud Pharma S.L.U., IntelGenx Corp., IntelGenX Technologies Corp., Xiromed, LLC, Chemo Research, S.L., Insud Pharma S.L., IntelGenx Technologies Corp. Signed by Judge Colm F. Connolly on 2/15/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(nmf) (Entered: 02/15/2023)